Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H19O2.Na |
| Molecular Weight | 242.2892 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCC(C([O-])=O)C1=CC=C(CC(C)C)C=C1
InChI
InChIKey=SJBWJHOBCVAGGD-UHFFFAOYSA-M
InChI=1S/C14H20O2.Na/c1-4-13(14(15)16)12-7-5-11(6-8-12)9-10(2)3;/h5-8,10,13H,4,9H2,1-3H3,(H,15,16);/q;+1/p-1
Butibufen is a non-steroidal anti-inflammatory cyclooxygenase inhibitor with analgesic and antipyretic properties. The drug was investigated for the treatment of osteoarthritis, rheumatoid artritis, and other arthroses. It was marketed under tradenames Mijal and Butilopan but now is withdrawn from the market.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2094253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10579692 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
60682-24-8
Created by
admin on Mon Mar 31 23:38:20 GMT 2025 , Edited by admin on Mon Mar 31 23:38:20 GMT 2025
|
PRIMARY | |||
|
DTXSID40976119
Created by
admin on Mon Mar 31 23:38:20 GMT 2025 , Edited by admin on Mon Mar 31 23:38:20 GMT 2025
|
PRIMARY | |||
|
262-374-3
Created by
admin on Mon Mar 31 23:38:20 GMT 2025 , Edited by admin on Mon Mar 31 23:38:20 GMT 2025
|
PRIMARY | |||
|
33KW1RW80I
Created by
admin on Mon Mar 31 23:38:20 GMT 2025 , Edited by admin on Mon Mar 31 23:38:20 GMT 2025
|
PRIMARY | |||
|
23674255
Created by
admin on Mon Mar 31 23:38:20 GMT 2025 , Edited by admin on Mon Mar 31 23:38:20 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD